Rexulti 0.25 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3R2W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,321
Award facts
- Contract value 100% obligated
- $31,320.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 15, 2026, for Rexulti 0.25 mg tablet 30-count units with a ceiling value of $31,320.55.
The order is issued under a DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order carries a firm fixed price structure with an ultimate completion date of April 16, 2026, and was awarded without set-aside on a competitive basis.
Quick answers
Who was awarded contract SPE2DR26F3R2W?
SPE2DR26F3R2W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 15, 2026.
How much is contract SPE2DR26F3R2W worth?
The government has obligated $31,321 on SPE2DR26F3R2W.
Is contract SPE2DR26F3R2W an order under another contract?
Yes. SPE2DR26F3R2W is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3R2W competed?
The extent of competition for SPE2DR26F3R2W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award